Among other projects receiving funding under the School's Funding Round 14, Professor Deaton was awarded a grant of £633,846 for the research: “Optimising Management of Patients with Heart Failure with Preserved Ejection Fraction in Primary Care”. Read more about the research on the University of Cambridge website.
This is a tremendous opportunity to improve the care of a vulnerable group for whom there is little evidence for management. About 50% of patients with heart failure have a preserved ejection fraction, and they are typically older with multiple comorbid conditions. Management of comorbidities is thought to be key to managing HFpEF, as these proinflammatory conditions drive the development and progression of HFpEF. However we also need to consider the burden of treatment that this imposes on patients who may have advanced age and frailty.”
- Prof Christi Deaton